Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Prognostic biomarkers and next generation genomic sequencing

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 21.05.12
Views: 2900

Prof Stefan Pfister – Cancer Research Centre, Heidelberg, Germany

Professor Stefan Pfister talks to ecancer about identifying prognostic biomarkers and next generation genomic sequencing at the European Forum on Oncology in Berlin, May 2012.


Working within the German Consortium for Translational Cancer Research, Prof Pfister explains their goals of increasing translational oncology in research and in the clinic. In the future, they hope to exploit sequencing technology in diagnostics so tumour and blood sequencing can take place for each patient.

Related videos

follow us

Breast Cancer CDK 4/6

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation